Germany's Stada banks on branded drugs to shore up growth

October 5, 2016 8:27 AM

15 0

FRANKFURT Oct 5 Stada, the German generic drugmaker whose chairman was ousted by disgruntled investors, said it was banking on branded products to underpin longer term growth.

The company said on Wednesday that its target of group sales of 5 percent on average per year until 2019 would be driven by 8 percent growth per year at the branded products business, which makes brand-name prescription drugs that have lost patent protection as well as branded non-prescription drugs...

Also read: Fed's Kaplan says he has no problem with being 'restrictive'

Read more

To category page